FDA approves first AI test to guide breast cancer chemotherapy decisions
Posted:
According to estimates from 2022, about 2.3 million females around the world were newly diagnosed with breast cancer..The U.S. FDA recently cleared the ArteraAI Breast digital pathology-based risk stratification tool to help doctors predict the likelihood of metastasis in patients with early-stage HR+/HER2- breast cancer to help determine the intensity of their treatment.
The MHRA published the findings of the National Commission into the Regulation of AI in Healthcare's Call for Evidence, the most substantial assessment yet of how the UK should regulate AI in health and care. The Commission is the independent advisory group…
Hospices across England are being offered access to a new NHS-backed AI programme designed to give doctors and nurses more time with patients during the final stages of life.
The initiative will provide selected hospices with free access to CLEARnotes,…
Attendees
Sponsors and Exhibitors
Contact us